ScripUnicycive Therapeutics was started by a single person, went public through an IPO in 2021, and four years later is preparing to continue its track record of proving skeptics wrong by independently lau
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C
Pink SheetThe UK’s originator drugs and generics industries are at odds over a rise in the clawbacks that companies must pay the government on the sales of branded medicines to the National Health Service under
In VivoAt its core, Mirum Pharma is a business development success story. CEO Chris Peetz sat down with In Vivo to discuss Mirum’s commercial momentum, near-term catalysts and the company’s vision for beco